* Threats of ECB action keeps euro subdued
* Oil prices fall on rising supplies
* U.S. bond prices slip before two-year supply (Adds close of European bond, stock markets)
By Herbert Lash
NEW YORK (Frankfurt: HX6.F - news) , April 22 (Reuters) - Global equity markets rose on Tuesday, powered by solid U.S. corporate earnings and deal-making activity among European drugmakers, while the euro edged above break-even.
On Wall Street, the S&P 500 and the Nasdaq were on track for a sixth straight session of gains, led by gains in technology shares. In Europe, an index of top European shares finished up 1.3 percent, the biggest daily gain since early March.
Netflix Inc, the video streaming company, surged 5.5 percent to $367.74 a day after it reported quarterly results that showed strong subscriber growth, a sign the company's shares could continue to rise despite valuation concerns.
One-fifth of the companies in the S&P index have reported first-quarter earnings so far, of which 63 percent beat analysts expectations. The rate is in line with a 20-year average but down from the 66 percent average of the past four quarters.
"The season has been better than many have feared, which is helping investors feel comfortable with the pace of economic growth, not just in the first quarter but going forward," said Joseph Tanious, global market strategist at J.P. Morgan Asset Management in New York.
The Dow Jones industrial average rose 107.5 points, or 0.65 percent, to 16,556.75. The S&P 500 gained 11.3 points, or 0.6 percent, to 1,883.19, and the Nasdaq Composite added 42.562 points, or 1.03 percent, to 4,164.108.
AstraZeneca (NYSE: AZN - news) jumped 4.7 percent in London after the Sunday Times newspaper reported Pfizer (NYSE: PFE - news) approached its British rival with a 60 billion pound ($101 billion) takeover offer. Pfizer rose 1.2 percent to $31.23.
GlaxoSmithKline (Other OTC: GLAXF - news) rose 5.2 percent after it agreed to sell its oncology products to Novartis (Xetra: NOT.DE - news) for $14.5 billion, while buying the Swiss firm's vaccines, excluding flu. Novartis' shares were up 2.3 percent.
Investors trimmed their positions of U.S. dollars after a two-week run higher, unmoved by data on U.S. existing home sales for March that beat expectations but showed a modest decline from the prior month.
The euro gave up some of its modest gains, but remained slightly positive against the greenback and yen.
The euro slipped to a two-week low of $1.3783 at one point, before trading 0.08 percent higher at 1.3802.
ECB executive board member Benoit Coeure said on Tuesday that there was further margin to reduce the main interest rate below 0.25 percent and that the strength of the euro could be keeping inflation too low.
But until the ECB takes action, traders said the euro was unlikely to weaken much, thus keeping it tied to a range.
The dollar edged lower at 102.59 yen.
Brent oil fell and the U.S. benchmark posted a sharper decline on forecasts of rising crude stocks, but a faltering pact to ease tensions in Ukraine offered some support.
Brent crude was down 88 cents at $109.07 a barrel, after reaching a six-week high of $110.36 last week. U.S. crude slipped $2.15 cents to $102.22 a barrel.
U.S. Treasuries prices fell, with benchmark yields at their highest level in two weeks, in advance of an auction of $32 billion in two-year notes, the first part of this week's $96 billion in coupon-bearing supply.
Benchmark 10-year Treasuries notes last traded 2/32 lower in price to yield 2.7297 percent,
(Reporting by Herbert Lash; Additional reporting by Marius Zaharia in London; Editing by Leslie Adler)